Add BrightSurf on Google Email

The Lancet


Patients with high blood pressure respond better to combination therapy rather than single-drug therapy from the start of treatment (ACCELERATE study)

Patients with high blood pressure respond better to combination therapy from the start of treatment, with a mean reduction in systolic blood pressure of 6.5 mm Hg. After switching to combination therapy, patients who initially received monotherapy show improvement but not to the same extent as those on combination therapy from the start.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 12, 2011

Intensity-modulated radiotherapy protects saliva function and improves quality of life for head and neck cancer patients compared with conventional radiotherapy (PARSPORT trial)

The PARSPORT trial found that intensity-modulated radiotherapy (IMRT) spares the major salivary glands, reducing xerostomia and improving quality of life in head and neck cancer patients. IMRT significantly reduces the incidence of dry mouth and leads to recovery of saliva secretion.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJan 12, 2011

Lancet supports Academy of Medical Sciences recommendations for massively reducing the bureaucracy and difficulty of UK health research by creating a single health research agency

The Lancet Editorial backs the Academy of Medical Sciences' proposal for a single health research agency to streamline current arrangements and improve oversight. The new agency would house National Research Ethics Service and take responsibility for specialist research ethics approvals.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 10, 2011

Study of UK TB patients shows that some recover more quickly if their antibiotics are supplemented with high-dose vitamin D

A new study found that supplementing antibiotics with high-dose vitamin D can significantly reduce the time needed for TB bacteria to clear from sputum culture by almost a week in patients with specific genetic profiles. The treatment improved response in those with the tt genotype of the TaqI vitamin D receptor polymorphism.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 5, 2011

Rituximab maintenance significantly improves progression-free survival in patients with follicular lymphoma

The PRIMA study found that rituximab-maintenance therapy significantly improved progression-free survival and response rates compared to no treatment in patients with follicular lymphoma. After 2 years, 71.5% of patients in the rituximab group achieved complete or unconfirmed complete response compared to 52.2% in the observation group.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 20, 2010

Treating worms during pregnancy might not be associated with wider health benefits for infants in developing countries and policy recommendations should be reviewed

A study published in The Lancet found that deworming treatment during pregnancy does not affect infant immune responses to vaccines or infectious disease incidence. The authors suggest that the value of this intervention should be re-examined, and policy recommendations be reviewed.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 20, 2010

London: The tuberculosis capital of Europe

The UK is experiencing a resurgence of tuberculosis, with London accounting for over 40% of all TB cases. The disease is concentrated in high-risk groups, including migrants, homeless people, and prisoners. Experts call for urgent recommendations to be implemented to control the spread.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 16, 2010

Adjuvanted HINI vaccine induces a more rapid and stronger immune response than whole-virus vaccine, particularly in young adults

A head-to-head trial found that the adjuvanted split-virus vaccine achieved a more rapid and stronger immune response than the whole-virus vaccine. In young adults, a single dose of the adjuvanted vaccine induced early seroprotection within one week, suggesting potential for reduced dosing frequency.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateDec 16, 2010

Dealing with an epidemic of loneliness

A UK doctor shares a poignant story of an elderly patient struggling with loneliness, highlighting the need for companionship and support. The Lancet argues that tackling loneliness requires a multi-faceted approach, including social clubs, workshops, and simply spending time with neighbors.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 15, 2010

Study shows that counselling-led by a lay person works well for depression and anxiety in public health facilities in Goa, India (MANAS trial)

A cluster randomised trial found that a collaborative stepped-care intervention led by lay health counsellors significantly improved recovery rates from common mental disorders among patients attending public primary care facilities. The intervention showed a greater effect in public facilities compared to private ones.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 13, 2010

Study confirms long-lasting benefit of radiotherapy for localized breast cancer, and reports importance of tamoxifen for reducing recurrence

Women with ductal carcinoma in situ (DCIS) who undergo radiotherapy after surgery experience a significant reduction in local cancer recurrences and invasive disease, with the effect lasting long-term. Treatment with tamoxifen also reduces recurrence rates, particularly in the opposite breast.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateDec 7, 2010

Pilots of the future: Suicide and the internet

The internet can provide anonymous space for expressing oneself and finding sympathetic listeners, but also poses risks of bullying, cyberbullying, and exposure to harmful information. Experts call for new public health initiatives to address the complex issue of online suicide prevention.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 2, 2010

Study identifies promising biomarkers for Huntington's disease that could be used to test disease-modifying treatments

A new study has identified promising biomarkers for Huntington's disease that could be used to track disease progression and test potential disease-modifying treatments. Biomarkers were found in brain imaging techniques, including whole-brain and striatal atrophy, which increased at a higher rate in individuals with the disease.

SourceThe Lancet_DELETED·JournalThe Lancet Neurology·DateDec 1, 2010

Health-care-acquired infections greatly increase risk of dying in intensive care, but additional impact of antimicrobial resistance is small

Critically ill patients with bloodstream infections and pneumonia face a greatly increased risk of dying, but the impact of antimicrobial resistance on patient outcomes is relatively small. The study analyzed data from over 500 intensive care units in ten European countries, finding that infections directly worsen outcomes for patients.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateNov 30, 2010

More than 600,000 deaths per year worldwide -- 1 perecent of all deaths -- caused by passive smoking, and around 165,000 of these deaths are among children

A study published in The Lancet reveals that passive smoking claims the lives of over 600,000 people each year globally, mostly among children. The research found that children are more heavily exposed to second-hand smoke than other age groups, and their exposure can have devastating effects on their health.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 25, 2010

Could Facebook trigger asthma?

Researchers report a case of an 18-year-old man experiencing asthma attacks triggered by logging into Facebook. The doctors suggest hyperventilation due to seeing his girlfriend's profile may have caused these episodes. They propose considering social networks as a potential trigger for exacerbations in depressed asthmatic individuals.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 18, 2010

Deactivating nerves in the kidneys reduces high blood pressure in patients not responding to drug treatment (Symplicity HTN-2 trial)

The Symplicity HTN-2 trial shows that deactivating nerves in the kidneys using radiofrequency energy can significantly reduce blood pressure in patients with treatment-resistant hypertension. The study found a large reduction in systolic blood pressure, and the technique was applied without major complications.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 17, 2010

'If chronic diseases are ignored we will sleepwalk into a world where healthy people are a minority and unhealthy children die before their parents'

The NCD Alliance warns that ignoring chronic diseases will lead to a future where healthy people are in the minority, while unhealthy children die before their parents. The alliance calls for effective actions on diet, physical activity, risks, and determinants related to non-communicable diseases.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 10, 2010

Combined approach including taxing unhealthy foods, restricting food advertising and better labeling are among most cost-effective ways to reduce obesity in nations of all incomes

A combined approach of taxing unhealthy foods, restricting food advertising, and improving labeling is cost-effective in reducing obesity in all nations. Implementing such measures would add nearly 7 million life years to the population's health expectancy.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 10, 2010

Dabigatran is as effective as warfarin in preventing stroke in patients with prior transient ischaemic attack or stroke and has a lower risk of intracranial bleeding

A new anticoagulant drug dabigatran has been found to be equally effective as warfarin in preventing stroke in patients who have previously had a stroke or transient ischaemic attack. The study also showed that dabigatran has a lower risk of intracranial bleeding compared to warfarin.

SourceThe Lancet_DELETED·JournalThe Lancet Neurology·DateNov 7, 2010

Targeted human papillomarvirus vaccination: A cost-effective intervention against anal cancer in men who have sex with men

A recent study found that targeted human papillomavirus (HPV) vaccination in men who have sex with men is a cost-effective intervention against anal cancer. The quadrivalent vaccine has demonstrated high efficacy against anal lesions and genital warts in young MSM. Vaccination at ages 12-26 years without previous exposure to HPV-target...

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateNov 2, 2010